Friday, 21 February 2020

BioLargo Announces Crowdfunding Offering of Water Subsidiary Opportunity to Invest in Water Treatment Technology

PR Newswire

WESTMINSTER, Calif., Feb. 19, 2020 /PRNewswire/ -- BioLargo, Inc. (OTCQB:BLGO), developer of sustainable technologies and a full-service environmental engineering company, announced today that it has commenced a Regulation Crowdfunding offering (details at waterworksfund.com/biolargo) through its wholly-owned-subsidiary BioLargo Water Investment Group, Inc. ("BWIG") to support efforts to launch its patented water treatment technology into the $246 million poultry processing market.









Every year, nine billion chickens are processed in the United States, creating approximately 60 billion gallons of contaminated wastewater. The new technology, developed by BioLargo through its Alberta-based Canadian wholly-owned-subsidiary of BWIG, can efficiently treat this polluted water, enabling safe wastewater discharge and even water reuse.

BioLargo Water's treatment technology, called the Advanced Oxidation System (AOS), eliminates bacteria, viruses, and other pathogenic organisms, and can reduce pharmaceuticals and antibiotics. It is more effective in removing water contaminants than most standard systems typically used to treat industrial wastewater, and the treated water is clean enough for safe discharge to the environment or reuse in the facility. BioLargo Water's treatment technology also uses less power and is more affordable to purchase and operate than chlorination, ozonation, and UV radiation, providing additional cost savings to processors.

BioLargo Water's technology has been tested at a poultry farm in Canada, a microbrewery in Southern California, and at a stormwater site in Southern California.  After launching into the poultry processing market, BioLargo Water intends to enter the $44 billion markets of stormwater, food and beverage, municipal, industrial, oil and gas, and agriculture wastewater.

BioLargo Water has been awarded over 70 grants for development and commercialization of water treatment technology, is supported by more than 20 industry and academic collaborators from around the world, and has received financial support from innovation-centric agencies in the Canada and United States, including the Metropolitan Water District of Southern California.

To learn more, visit www.waterworksfund.com/biolargo.


About BioLargo, Inc.
BioLargo, Inc. is an innovative technology developer and environmental engineering company driven by a mission to "make life better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We develop and commercialize disruptive technologies by providing the capital, support, and expertise to expedite them from "cradle" to "maturity" (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.com) is preparing to commercialize its Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.

About BioLargo Water Investment Group, Inc.
BioLargo Water Investment Group, Inc. is a wholly-owned-subsidiary of BioLargo, Inc., and the sole shareholder of BioLargo Water, Inc., a Canadian entity formed by BioLargo to develop water treatment technologies and products. BioLargo Water Investment Group was established to facilitate a vehicle in which investors are able to invest along-side BioLargo to advance and support the business plan of BioLargo Water through its piloting work and into commercialization. The structure is also organized to carefully preserve BioLargo Water's valuable Canadian status in order to encourage and maximize its ongoing financial support from its various federal sources of funding in Canada. Headquartered at Agri-Food Discovery Place located on campus at the University of Alberta in Edmonton, BioLargo Water, Inc. is preparing to commercialize the Advanced Oxidation System (AOS), a patented and proprietary technology aimed at providing cost- and energy-efficient treatment of water and wastewater to enable practical and affordable safe discharge and reuse of diverse water sources. Learn more at www.biolargowater.com.

About WaterWorks
"WaterWorks" refers to a group of companies that is owned by WWF Holdings, Inc., which includes WWF Platform, LLC, WWF Crowd, LLC, WWF Agency, LLC, and WWF Funding Portal, LLC. WWF Funding Portal, LLC is registered with the U.S. Securities and Exchange Commission ("SEC") as a funding portal and is a member of the Financial Industry Regulatory Authority ("FINRA"). Investing involves the risk of loss. Past performance is not a guarantee of future results. Investments in private companies are particularly risky and you should only consider investing if you can afford to lose your entire investment and are willing to live with the ups and downs with the industry in which you invest.

Contact Information
Dennis P. Calvert
President & CEO of BioLargo, Inc.
(888) 400-2863
Dennis.calvert@biolargo.com

Wednesday, 12 February 2020

BioLargo Expands Global Reach, Signs Joint Venture Agreement with BKT & Tomorrow Water featuring CupriDyne Clean Based Products


Westminster, CA – February 12, 2020 – BioLargo, Inc. (OTCQB:BLGO), developer of sustainable technologies and a full-service environmental engineering company announced that it had executed a “Joint Venture Framework Agreement” with a leading wastewater treatment solution provider based in South Korea (Bookang Tech Co. Ltd., “BKT”), to create a South Korean entity that would manufacture odor and VOC control products based on CupriDyne® Clean, the award-winning product of BioLargo’s subsidiary Odor-No-More, Inc. The parties intend to form the joint venture (JV) promptly and begin operations as soon as possible.

CupriDyne Clean is Odor-No-More’s patented product that controls odors and VOCs at landfills and transfer stations operated by the largest waste handling companies in the United States. CupriDyne Clean is lauded for its gentle, non-toxic, eco-friendly, non-pesticide formula that works by eliminating odor-causing compounds rather than masking them.

BKT is a leading wastewater treatment solutions provider operating in the USA, South Korea and Vietnam with a reputation for adopting innovative, environmentally sustainable technologies and practices. Headquartered in Daejeon, South Korea, BKT has an extensive distribution network throughout Southeast Asia serving more than 400 customers in South Korea alone, and has a presence in more than eight countries globally.

CEO and Founder of BKT and Tomorrow Water Dong Woo Kim commented on the formation of the JV with BioLargo, “Odor-No-More’s products have performed extremely well in our tests, and their team has demonstrated utmost expertise in creating innovative, eco-friendly solutions for air quality control in the wastewater treatment sector. We are looking forward to introducing these products to our customers.”

Under the terms of the agreement, BioLargo will invest $100,000 in the JV, while BKT and its U.S.-based subsidiary Tomorrow Water will invest $75,000 each, for proportionate non-dilutive interests. The JV will manufacture the CupriDyne Clean-based odor and VOC control product for distributors throughout Southeast Asia, including BKT. The JV must achieve minimum sales targets to maintain exclusive rights in the Asian markets, and an annual dividend of $2 million paid to BioLargo to secure exclusive rights in perpetuity. Finally, BKT has also agreed to invest $350,000 USD directly into BioLargo, Inc. through a stock purchase priced at market prices at closing, which is contemplated within 60 days.

BioLargo President & CEO Dennis P. Calvert said, “Not only is BKT a prominent and well-established solutions provider in the Southeast Asian wastewater industry, but they have demonstrated a commitment to innovation and research in the very DNA of their company. They are well-known for their quality service offering and integrity, and we at BioLargo are confident that together we will prosper through the formation of this joint venture.”

Joseph Provenzano, President of Odor-No-More, Inc. commented, “It’s uncommon to find an international distribution partner as qualified and capable as BKT, and for this reason we are highly encouraged about the potential for this joint venture to grow sales of CupriDyne Clean and related products significantly.”

About BKT, Tomorrow Water
BKT is a leading environmental solutions provider, specialized in biological treatment, physical filtration and integrated process design. With over 20 years of experience, BKT is committed to solving the world’s challenges of today, while designing comprehensive solutions for the needs of tomorrow. Our Proteus BBF Biofilitration (https://www.tomorrowwater.com/technology-bbf) is a proven technology that combines physical and biological filtration for advanced primary treatment, which also can be applied to secondary and tertiary treatment process. Proteus (BBF), when applied primary treatment, shrinks existing process footprints up to 80%, while maximizing economic benefits such as carbon diversion and more energy production. Our unique 2-stage AMX™ (https://www.tomorrowwater.com/technology-amx) is the most resilient Anammox system and is pioneering new shortcuts in nitrogen removal. With our diverse portfolio of technologies and dedicated team of researchers and engineers, we strive to maximize recovering the most value from waste and wastewater, while minimizing the environmental impact of it.

About BioLargo, Inc.
BioLargo, Inc. is an innovative technology developer and environmental engineering company driven by a mission to "make life better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We develop and commercialize disruptive technologies by providing the capital, support, and expertise to expedite them from "cradle" to "maturity" (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.

Contact Information
Dennis P. Calvert
President & CEO, BioLargo, Inc.
(888) 400-2863

Safe Harbor Act
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

Thursday, 6 February 2020

BioLargo engineers top-notch, low-cost answer to PFAS water contamination problem

Source: Proactive Investors







Scared about “forever chemicals” after watching ‘Dark Waters?’
The movie is based on a true story. Rob Bilott was a high-flying corporate defense attorney for eight years. Then he took on an environmental lawsuit that would upend his entire career — and expose a brazen, decades-long history of chemical pollution.
Sadly, people still drink water contaminated with man-made “forever chemicals." The chemicals, resistant to breaking down in the environment, are known as poly and perfluoroalkyl substances, or PFASs. They are typically used in fire retardants, oil and water repellents, furniture, waterproof clothes, take-out containers and non-stick cookware.
They are called “forever chemicals” because it could take thousands of years for them to naturally break down. These chemicals have been linked to cancers, liver damage, low birth weight and other health problems.
Fortunately, BioLargo Inc’s (OTCMKTS:BLGO) subsidiary BioLargo Engineering, Science & Technologies Inc (BLEST), has confirmed the potential of a new water treatment technology to solve the global drinking water contamination problem.
Proactive sat down with Randall Moore, who is president and CEO of BLEST, to find out about progress on a device called the Aqueous Electrostatic Concentrator (AEC) that is effective in eliminating PFAS from water. The new technology eliminates more than 99% of the two most predominant PFAS compounds – perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA).
What are some of the concerns about people being exposed to a toxic soup of PFAS chemicals?
There are numerous articles in the popular press about PFAS compounds being tied to myriad health problems, including various forms of cancer, liver and kidney disfunction, high cholesterol and weight gain. The hard, peer-reviewed science hasn’t caught up with the public demand for answers to the effects of long-term, low-level exposure as opposed to acute exposure. 
However, a couple of points are undeniable. Firstly, these compounds don’t occur in nature, so nature hasn’t yet produced a biological means to degrade them. Secondly, PFAS compounds bioaccumulate. That is, the human body doesn’t do a good job in clearing PFAS from the body, taking decades after exposure to get rid of the compounds in the bloodstream.
Can you talk about BioLargo Engineering’s PFAS technology project and the support it has received from the US Environmental Protection Agency (EPA)? 
BioLargo received a Phase I, EPA grant through the SBIR program. The grant supported the design, development and testing of the new bench scale PFAS treatment device, which we named the Aqueous Electrostatic Concentrator. The EPA has published a summary of the Phase 1 study on their website. 
How effective is BLEST’s Aqueous Electrostatic Concentrator (AEC) in eliminating PFAS chemicals?
The AEC performance exceeded our expectations, achieving over 99% removal of PFOA and PFOS in a single stage unit. In practice, we expect to use multiple stages, each stage optimized to target smaller and smaller concentrations of PFAS, until water is produced that has no detectable PFAS chemical present. Our original thinking was that PFAS would be treated like other water contaminants and that water below some threshold concentration would be acceptable for public use. However, recent legislation and events that have eroded the lack of public trust have pushed the acceptable threshold concentrations to the detection limit of the methods. Our Phase I work confirmed we can meet those ultra-low thresholds using the AEC.
Since BioLargo has completed Phase 1, which involved the design, build and testing of its technology to remove PFAS from water, what does the next phase involve?
Phase II work will involve confirming that the AEC is as effective on the rest of the PFAS target list compounds. Based on the principle of operation, it is logical to conclude that the AEC will be equally effective on the other polar PFAS compounds. However, it is important to make sure. And the best way to confirm the performance is to do the study. There’s also considerable support under Phase II for commercial development, market evaluation and penetration. By the end of Phase II, we expect to have commercial scale pilot systems in operation, treating contaminated plumes in real-world situations. 
Can you demystify the technology behind the AEC and why it’s so easy on the pocket?
The PFAS compounds of concern have functional groups on one end of the PFAS molecule that cause it to behave similarly to an ionized polar compound in solution. In other words, one end of the compound has a slight negative charge, while the other end does not exhibit an electrical charge in solution. Therefore, the PFAS molecule is attracted to an electrode that is positively charged. Our system puts a proprietary membrane in the migration path of PFAS compound, effectively capturing and retaining the contaminant. 
The amount of work done (energy expended) on the system can be very small, since the concentration of PFAS contamination even in highly contaminated water is very small. The Phase I tests demonstrated that the lower the PFAS concentrations, the less energy has to be expended to remove it. So, the operating costs can be very attractive compared to higher energy consuming technologies such as reverse osmosis. The AEC can be constructed from “off the shelf” components and doesn’t require exotic materials to operate effectively, which keeps the capital costs under control.   
With this proof of claim in hand, how far are we from seeing the AEC gain traction in the mainstream water treatment market?
There are two primary markets for PFAS treatment systems. The first, is the direct treatment of contaminated plumes of PFAS in ground water. The second is treatment of drinking water. The smallest system applicable for treating drinking water will be in the 10,000 gallon per minute range. Our initial target is the direct treatment of contaminated plumes, which can be addressed with smaller systems from 10 gallons per minute (GPM) to say, 500 GPM. Once a 500 GPM unit is in operation and demonstrates performance, we can move into the larger systems. Assuming we can secure private funding to match our recently secured Phase II EPA funds, we can have units to address the ground water plume treatment market within a year.
Would BioLargo license or partner the technology with a big player to secure the funds to make tens of thousands of units in the shortest time possible?
First, it is important to remember that our engineering and science teams at BioLargo have had extensive and successful careers dealing with some of the most significant remediation challenges. We've had long careers working with large customers and governments around the world. We joined the BioLargo family of companies so that we could put our skills to work to help solve some of the most difficult and pressing issues facing our planet, just like this PFAS situation.
While we have the experience of dealing with every facet of the execution of projects just like this one, including design, build and operate projects, we realize that the opportunity is global and will likely move so fast that we must explore all rational options to scale-up and deliver solutions as fast as possible. As always, we will be accessing how best to provide the greatest benefit and value to our clients. We obviously will need to build business relationships that support large-scale, national and international deployment. As we prove out our high-performance low-cost thesis, we believe business opportunities will expand around the world quickly. We are also looking into teaming with providers of other technologies to offer complete water solutions to the marketplace.  
How big is the PFAS clean-up market? 
The short answer is: Huge. The market is so large it’s hard to put a number to it. Environmental costs for the cleanup of previous contamination from PCBs, dioxin, lead, etc. were incredibly large. But the extent of contamination was contained within known geographic areas and the number of sites escalated more slowly over time. In comparison, PFAS contamination is seemingly ubiquitous and not as constrained by physical barriers, causing the contamination to spread almost unimpeded. The number of identified contaminated sites grows daily and the number will continue to escalate rapidly as water suppliers begin to look for contamination in earnest. There were 610 sites in 43 states as of May 2019. There are over 400 sites on military bases alone. I expect the final tally to exceed 2,000 identified sites in the US. Orange County California estimates the cost to treat the 90 wells already confirmed to be contaminated with PFAS at $850 million using conventional techniques. 
Based on our estimates of the cost of equipment required to address the market, we think the equipment market could be at least $200-$400 million for small units. Many municipalities are also installing “whole city” treatment systems, which could easily cost more than $40 million each. So, the total equipment supply market could easily exceed $1 billion. 
However, the larger costs will include maintenance, repair, and testing of the systems, adding another $2 billion. Additionally, the final disposal of the collected PFAS must be considered. The disposal costs could also exceed $2 billion. We would expect the total addressable market to grow to well over $10 billion before the cleanup is complete. The truth is that the world is just getting its arms around the breadth of the problem and they don’t yet know about our AEC high-performance low-cost solution that should help relieve some of the financial pain.
Contact the author Uttara Choudhury at uttara@proactiveinvestors.com
Follow her on Twitter: @UttaraProactive 

Tuesday, 28 January 2020

BioLargo Engineering Is Tackling PFAS Head-On With New Treatment Technology — Moving To Next Phase Of Groundbreaking PFAS Work

Oak Ridge, TN – BioLargo Engineering, Science & Technologies (BLEST), today announced that it has validated the efficacy of a new, cutting-edge water treatment technology aimed at solving the growing international per- and polyfluoroalkyl substances (PFAS) contamination crisis. Having completed its work under a Phase I SBIR grant from the EPA to its parent corporation BioLargo, Inc. (OTCQB:BLGO), it is moving to the next phase of development in preparation for demonstration pilots and commercialization.
The new technology, called the Aqueous Electrostatic Concentrator (AEC), has been proven capable of 99+% removal of the two most predominant PFAS compounds – PFOA and PFOS – without the need for the high-pressure systems and high electricity costs of reverse osmosis, or the high consumable costs necessary for carbon filters. BLEST reports that based on its bench-scale testing, AEC was projected to use only $0.30 of electricity to treat 1,000 gallons of water, a fraction of the cost of what is necessary to operate the competing technologies. BLEST management believes that they will further reduce electricity costs for treating potable water.  
Described as “forever chemicals” by Washington DC based environmental watchdog the Environmental Working Group, PFAS contamination is estimated to affect up to 110 million people in the United States. Numerous experts have linked PFAS to detrimental effects on human health and the environment due to their tendency to accumulate and persist in the environment and human body. On January 7, 2020, EPA Administrator Andrew Wheeler announced that “aggressively addressing per-and polyfluoroalkyl substances (PFAS) is an active and ongoing priority for the U.S. Environmental Protection Agency.” The two common and widespread PFAS compounds addressed by the BLEST study – PFOA and PFOS – are found in common household and industrial products. Both compounds have been found in water supplies across the country, and municipalities are struggling to find a feasible and affordable solution to remove PFAS from their drinking water.
Funded in part by an SBIR Phase I grant administered through the EPA, BLEST’s initial work successfully established that the AEC could remove high concentrations PFAS in a continuous flow-through device, producing a “clean” stream and a highly concentrated PFAS stream ready for subsequent treatment by methods like advanced oxidation. The AEC technology has potential to significantly reduce the cost of water treatment in a full-scale application.
The BLEST team has submitted an application for additional funding from the EPA to accelerate its work under a Phase II SBIR grant. In the proposed project, the team will create a pilot unit to field test the technology in commercial and industrial settings at a small commercial scale. They are in the process of identifying a “partner community” that will act as the test site.  
Randall Moore, President of BLEST, commented, “We believe we have made a strong case in our application to the EPA for additional financial support under the Phase II SBIR grant program. Our team has decades of experience delivering engineering and science-based solutions. Our goal is to deliver a low-cost, low-energy technology that will reduce the threat PFAS poses to people worldwide.”  
BioLargo, Inc. President & CEO Dennis P. Calvert expanded on the commercial implications of the AEC, “We believe a solution to the PFAS crisis is directly in line with our mission, knowledge and experience. We have confidence in Randy, his team, and our group of scientists, and intend to support BLEST 100% as they move towards commercializing the AEC. We plan to get the technology field tested and launched commercially as soon as possible. We have the ability to help communities all over the world who face this PFAS challenge. This is another great example of how BioLargo has grown to become an innovator and full-service solution provider.”
For more information on this study and the work done by BLEST, the EPA has published the full Phase 1 report on their website at https://cfpub.epa.gov/ncer_abstracts/index.cfm/fuseaction/display.abstractDetail/abstract/10966/report/F. BLEST encourages anyone who is interested in PFAS treatment to read the study and reach out using the contact information below.
About BioLargo Engineering, Science & Technologies
Biolargo Engineering Science and Technology is a full-service engineering company based in Oak Ridge Tennessee. Part of the Biolargo, Inc. portfolio of life-science innovation companies, it works in conjunction with the other divisions which include Alberta Canada based BioLargo Water (innovation in low, energy advanced oxidation processes), Westminster California based Odor-No-More (innovative, safe and effective industrial odor control), and Clyra Medical Technologies (FDA approved wound care advancement). BLEST’s engineers bring over 100 years of combined experience in environmental science.  Find out more about this innovative company at www.biolargo.com or contact Tonya Chandler, Director of Strategic Marketing and Business Development at 608-397-8301 or tonya.chandler@biolargo.com
About BioLargo, Inc.
BioLargo, Inc. is an innovative technology developer and environmental engineering company driven by a mission to "make life better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We develop and commercialize disruptive technologies by providing the capital, support, and expertise to expedite them from "cradle" to "maturity" (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.

Wednesday, 15 January 2020

BioLargo Discusses 2020 Growth Strategy with the Stock Day Podcast


Phoenix, Arizona--(Newsfile Corp. - January 15, 2020) - The Stock Day Podcast welcomed BioLargo, Inc. (OTCQB: BLGO) ("the Company"), developer of sustainable products and a full-service environmental engineering company for an interview. President & CEO of the Company, Dennis P. Calvert, joined Stock Day host Everett Jolly.

Jolly began by noting that the Company recently added a new member to their sales and marketing team, Tonya Chandler. "Tonya is a 20-year veteran of the water and wastewater industry," shared Calvert. "She brings a wealth of talent and experience in developing real-life solutions in the field," he added. "It's really a great fit."

Jolly then commented on the Company's success throughout 2019 and asked about their strategy for 2020. "The challenge now is to manage the growth," said Calvert. "The trick for us is to narrow the focus on high-margin opportunities, high value to a customer, build out the team, and put a little capital behind the company for growth," said Calvert.

The conversation then turned to the Company's involvement in solutions for per- and polyfluoroalkyl substance (PFAS) water contamination. "Everyone is figuring out that this is a big problem," said Calvert, adding that the PFAS crisis poses a significant financial impact. "These compounds are stuck in the water. They are these forever-chemicals that are persistent and cumulative and have been linked to significant adverse health effects," said Calvert. "The world is looking for a solution," said Calvert.

"We've proved out in the first phase [of the EPA-funded project] that our solution works, and now we're in the scale-up mode. We have an application pending for a phase two [EPA SBIR] grant and have additional grants we're working on," shared Calvert. "What we believe we will bring to market is a low-cost solution that will allow us to extract these contaminants out of the water in a cost-effective way," said Calvert. "We do believe it is scalable, so the future is very bright."

To close the interview, Calvert expressed his confidence in the Company's technology and the potential it represents. "2020 is the year in which we see leveraged expansion," said Calvert. "This is going to be the year where we watch accelerated growth leverage through these relationships," closed Calvert.

To hear Dennis Calvert's entire interview, follow the link to the podcast here: https://audioboom.com/posts/7478778-biolargo-discusses-2020-growth-strategy-with-the-stock-day-podcast

Investors Hangout is a proud sponsor of "Stock Day," and Stock Day Media encourages listeners to visit the company's message board at https://investorshangout.com/


About BioLargo, Inc.

BioLargo, Inc. is an innovative technology developer and environmental engineering company driven by a mission to "make life better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We develop and commercialize disruptive technologies by providing the capital, support, and expertise to expedite them from "cradle" to "maturity" (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.

Contact Information

Dennis Calvert President and CEO BioLargo, Inc. 888-400-2863

Safe Harbor Act

This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

About The "Stock Day" Podcast

Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America. Stock Day recently launched its Video Interview Studio located in Phoenix, Arizona.

SOURCE:
Stock Day Media
602-441-3474

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/51500

Tuesday, 14 January 2020

BioLargo Welcomes Water Industry Veteran Tonya Chandler to its Sales and Marketing Team


Westminster, CA – January 14, 2020 – BioLargo, Inc. (OTCQB:BLGO), developer of sustainable products and a full-service environmental engineering company, today announced that water and wastewater industry veteran Tonya Chandler has joined the BioLargo team to serve as Director of Strategic Marketing and Business Development with a focus on advancing sales and marketing of the Company’s patented products and engineering services for water-related industries. The addition of Ms. Chandler to the BioLargo team comes as the company is working to commercialize its proprietary clean water technology the Advanced Oxidation System (AOS) starting in the poultry wastewater treatment sector and stormwater reuse markets.

Ms. Chandler has substantial experience delivering solutions for water treatment and odor control in the water and wastewater treatment industries. With more than 20 years of experience, she is a seasoned executive with a special focus on marketing and sales. Tonya is respected across the water industry for her ability to build lasting relationships, uncover business opportunities and develop cost effective solutions to serve customer needs.  She has special expertise in branding and innovation, international business, trade show and event coordination, publication writing and content creation, social media and digital marketing, project management, sales performance, and more. Her B2B and B2C sales, marketing, and channel management experience will serve a crucial role for all water and engineering services related markets for BioLargo.
Tonya Chandler, Director of Strategic Marketing and BD

Before joining BioLargo, Ms. Chandler was the Vice President of Sales and Marketing for Anue Water Technologies where she succeeded in growing the company’s sales pipeline dramatically. She has also served as a National Sales Manager for Veolia Water Technologies, as Regional Market Manager for Hydronautics, Inc., and as National Water Treatment Coordinator for Shaw Environmental & Infrastructure, Inc.

BioLargo President & CEO Dennis P. Calvert commented, “We intend Tonya to be an instrumental part of our team to help grow our business in the water sector as we deliver reliable, cost-effective solutions to some of the most troubling problems that afflict the world’s water and air.”


About BioLargo, Inc.
BioLargo, Inc. is an innovative technology developer and environmental engineering company driven by a mission to "make life better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We develop and commercialize disruptive technologies by providing the capital, support, and expertise to expedite them from "cradle" to "maturity" (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.

Contact Information

Dennis Calvert President and CEO BioLargo, Inc. 888-400-2863

Safe Harbor Act

This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

Monday, 13 January 2020

BioLargo Continues Record-Breaking Revenue Growth


·         Achieved Record Revenue in Q4 (>$560,000)
·         Achieved Record Revenue for 2019 (>$1.8 million)
·         Grew Total Revenue by 37% over prior year
Westminster, CA, January 13, 2020 – BioLargo, Inc. (OTCQB:BLGO), developer of sustainable products and a full-service environmental engineering company, today announced that it had set new quarterly and annual revenue records for 2019 and reported on key milestones for the year.
Financial Highlights
  • Achieved record revenue in fourth quarter 2019, more than $560,000
  • Achieved record revenue for calendar year 2019, more than $1.8 million
  • Grew revenue by 37% in calendar year 2019 compared with 2018
  • Increased revenues over the past two years by 10% per quarter
  • Generated positive cash flow for its subsidiary Odor-No-More
  • Retired all but $259,000 in variable priced convertible debt
  • Raised approximately $2.6 million in mandatorily convertible debt on friendly terms in summer 2019

Technical & Commercial Highlights
BioLargo hosting Oak Ridge Chamber of Commerce
  • Awarded EPA grant to test BioLargo’s proprietary solution to eliminate PFAS contaminants from water. Product test successful, company working on scale-up design
  • Validated its odor and VOC control product CupriDyne® Clean effectively breaks down hydrogen sulfide
  • Validated CupriDyne Clean breaks down terpenes, the odorous chemicals produced by the cannabis and hemp industry
  • Launched odor and VOC control products into the cannabis and hemp industry across North America through a third-party distributor
  • Received FDA 510(k) clearance for wound care product organizing for commercial launch through subsidiary Clyra Medical Technologies
  • Received 73rd government and industry research grant for AOS clean water technology
  • Successfully demonstrated AOS system treats poultry process water (commercial pilot organizing)
  • Successfully demonstrated spiral AOS works at high flow rates to enable continued scale-up
  • Successfully demonstrating AOS for storm water treatment in ongoing demonstration pilot
  • BioLargo Engineering won seven contracts to provide environmental engineering services to US Air Force bases
  • First AOS pilot unit
  • Signed memorandum of understanding with wastewater treatment company in South Korea, and the City of Daegu, South Korea, to develop manufacturing for Southeast Asia (contracts in process)

BioLargo President and CEO Dennis P. Calvert commented, “During 2019, we accomplished both commercial and technical breakthroughs in every operating unit, closing out the year by being named ‘Cleantech Company of the Year’ for Southern California by Sustain Southern California. Our award-winning technologies are validated and marching ahead to commercial adoption.  While we are proud of our accomplishments, we are certainly not satisfied because we believe our innovations will continue to grow and find large commercial markets around the world. We have only scratched the surface of our future potential.”
Mr. Calvert continued, “We expect the upward trends in revenue to continue. With appropriate growth capital and continued sales increases from our distributors, we believe we can grow our monthly revenue from $175k+ per month to over $350k+ a month by the end of the year, representing a 2X growth rate or more.
We have set forth the following goals for 2020:
Odor-No-More
ü  Grow monthly revenues 2-4X
ü  Expand sales by building distribution partnerships

BLEST Engineering
ü  Drive profitability from external contracts
ü  Support innovation, development and sales efforts
ü  Scale up BioLargo Engineering’s proprietary PFAS treatment technology

BioLargo Water
ü  Finance monthly operational costs through third-party investments
ü  Complete demonstration pilots for poultry process water and storm water treatment
ü  Publish academic papers validating the AOS
ü  Secure contracts for 3+ commercial clients
ü  Secure first commercial partner relationship

Clyra Medical Technologies
ü  Continue to finance through third-party investments
ü  Secure clinical validations and FDA approvals, as required for expanded uses of our wound irrigation solution (indications for use)
ü  Commercial launch of first product
ü  Prepare for the potential spin out and change in accounting from consolidated reporting to investment interest

We are very excited about 2020 and believe that our long-term stockholders will realize substantial value as we continue building a successful company. BioLargo’s depth of talent and technology is amazing and they position us well to be the solution provider of choice for clients and partners around the world.”

About BioLargo, Inc.
BioLargo, Inc. is an innovative technology developer and environmental engineering company driven by a mission to "make life better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We develop and commercialize disruptive technologies by providing the capital, support, and expertise to expedite them from "cradle" to "maturity" (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic wounds to promote infection control and regenerative tissue therapy.
Contact Information

Dennis Calvert President and CEO BioLargo, Inc. 888-400-2863

Safe Harbor Act

This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.